Finucane Thomas E
Johns Hopkins Bayview Medical Center, Baltimore, Maryland.
J Am Geriatr Soc. 2017 Aug;65(8):1650-1655. doi: 10.1111/jgs.14907. Epub 2017 May 19.
"Urinary tract infection" ("UTI") is an ambiguous, expansive, overused diagnosis that can lead to marked, harmful antibiotic overtreatment. "Significant bacteriuria," central to most definitions of "UTI," has little significance in identifying individuals who will benefit from treatment. "Urinary symptoms" are similarly uninformative. Neither criterion is well defined. Bacteriuria and symptoms remit and recur spontaneously. Treatment is standard for acute uncomplicated cystitis and common for asymptomatic bacteriuria, but definite benefits are few. Treatment for "UTI" in older adults with delirium and bacteriuria is widespread but no evidence supports the practice, and expert opinion opposes it. Sensitive diagnostic tests now demonstrate that healthy urinary tracts host a ubiquitous, complex microbial community. Recognition of this microbiome, largely undetectable using standard agar-based cultures, offers a new perspective on "UTI." Everyone is bacteriuric. From this perspective, most people who are treated for a "UTI" would probably be better off without treatment. Elderly adults, little studied in this regard, face particular risk. Invasive bacterial diseases such as pyelonephritis and bacteremic bacteriuria are also "UTIs." Mindful decisions about antibiotic use will require a far better understanding of how pathogenicity arises within microbial communities. It is likely that public education and meaningful informed-consent discussions about antibiotic treatment of bacteriuria, emphasizing potential harms and uncertain benefits, would reduce overtreatment. Emphasizing the microbiome's significance and using the term "urinary tract dysbiosis" instead of "UTI" might also help and might encourage mindful study of the relationships among host, aging, microbiome, disease, and antibiotic treatment.
“尿路感染”(“UTI”)是一个模糊、宽泛且过度使用的诊断术语,可能导致显著的、有害的抗生素过度治疗。“显著菌尿”是大多数“UTI”定义的核心,但在确定哪些个体将从治疗中获益方面意义不大。“尿路症状”同样缺乏信息量。这两个标准都没有明确的定义。菌尿和症状会自发缓解和复发。急性单纯性膀胱炎的治疗是标准做法,无症状菌尿的治疗也很常见,但明确的益处却很少。对伴有谵妄和菌尿的老年人进行“UTI”治疗很普遍,但没有证据支持这种做法,专家意见也反对这样做。现在,灵敏的诊断测试表明,健康的尿路中存在一个普遍存在的、复杂的微生物群落。认识到这个微生物群(使用基于标准琼脂的培养方法基本上检测不到)为“UTI”提供了一个新的视角。每个人都有菌尿。从这个角度来看,大多数接受“UTI”治疗的人如果不治疗可能会更好。在这方面研究较少的老年人面临着特殊风险。肾盂肾炎和菌血症性菌尿等侵袭性细菌性疾病也属于“UTIs”。要做出明智的抗生素使用决策,需要更好地了解微生物群落中致病性是如何产生的。很可能通过公众教育以及关于菌尿抗生素治疗的有意义的知情同意讨论,强调潜在危害和益处的不确定性,会减少过度治疗。强调微生物群的重要性并使用“尿路生态失调”而非“UTI”这个术语可能也会有所帮助,并且可能会鼓励对宿主、衰老、微生物群、疾病和抗生素治疗之间的关系进行审慎研究。